chr7-75984764-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001395413.1(POR):​c.1058-13C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.935 in 1,611,828 control chromosomes in the GnomAD database, including 710,378 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.85 ( 57007 hom., cov: 33)
Exomes 𝑓: 0.94 ( 653371 hom. )

Consequence

POR
NM_001395413.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -2.76

Publications

15 publications found
Variant links:
Genes affected
POR (HGNC:9208): (cytochrome p450 oxidoreductase) This gene encodes an endoplasmic reticulum membrane oxidoreductase that is essential for multiple metabolic processes, including reactions catalyzed by cytochrome P450 proteins for metabolism of steroid hormones, drugs and xenobiotics. The encoded protein has a flavin adenine dinucleotide (FAD)-binding domain and a flavodoxin-like domain which bind two cofactors, FAD and FMN, that allow it to donate electrons directly from NADPH to all microsomal P450 enzymes. Mutations in this gene cause a complex set of disorders, including apparent combined P450C17 and P450C21 deficiency, amenorrhea and disordered steroidogenesis, congenital adrenal hyperplasia and Antley-Bixler syndrome, that resemble those caused by defects in steroid metabolizing enzymes such as aromatase, 21-hydroxylase, and 17 alpha-hydroxylase. [provided by RefSeq, Aug 2020]
POR Gene-Disease associations (from GenCC):
  • Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia, Ambry Genetics
  • congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • Antley-Bixler syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 7-75984764-C-G is Benign according to our data. Variant chr7-75984764-C-G is described in ClinVar as Benign. ClinVar VariationId is 138789.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.957 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PORNM_001395413.1 linkc.1058-13C>G intron_variant Intron 10 of 15 ENST00000461988.6 NP_001382342.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PORENST00000461988.6 linkc.1058-13C>G intron_variant Intron 10 of 15 1 NM_001395413.1 ENSP00000419970.2 P16435

Frequencies

GnomAD3 genomes
AF:
0.852
AC:
129552
AN:
152008
Hom.:
56976
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.610
Gnomad AMI
AF:
0.923
Gnomad AMR
AF:
0.871
Gnomad ASJ
AF:
0.973
Gnomad EAS
AF:
0.855
Gnomad SAS
AF:
0.919
Gnomad FIN
AF:
0.978
Gnomad MID
AF:
0.934
Gnomad NFE
AF:
0.963
Gnomad OTH
AF:
0.878
GnomAD2 exomes
AF:
0.911
AC:
225464
AN:
247390
AF XY:
0.921
show subpopulations
Gnomad AFR exome
AF:
0.602
Gnomad AMR exome
AF:
0.840
Gnomad ASJ exome
AF:
0.975
Gnomad EAS exome
AF:
0.853
Gnomad FIN exome
AF:
0.977
Gnomad NFE exome
AF:
0.963
Gnomad OTH exome
AF:
0.933
GnomAD4 exome
AF:
0.944
AC:
1377896
AN:
1459702
Hom.:
653371
Cov.:
47
AF XY:
0.945
AC XY:
686189
AN XY:
726174
show subpopulations
African (AFR)
AF:
0.596
AC:
19907
AN:
33428
American (AMR)
AF:
0.848
AC:
37916
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.974
AC:
25450
AN:
26116
East Asian (EAS)
AF:
0.862
AC:
34210
AN:
39692
South Asian (SAS)
AF:
0.920
AC:
79319
AN:
86244
European-Finnish (FIN)
AF:
0.975
AC:
50794
AN:
52090
Middle Eastern (MID)
AF:
0.943
AC:
5432
AN:
5762
European-Non Finnish (NFE)
AF:
0.962
AC:
1069111
AN:
1111356
Other (OTH)
AF:
0.924
AC:
55757
AN:
60318
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
3614
7228
10842
14456
18070
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21564
43128
64692
86256
107820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.852
AC:
129635
AN:
152126
Hom.:
57007
Cov.:
33
AF XY:
0.854
AC XY:
63476
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.610
AC:
25284
AN:
41458
American (AMR)
AF:
0.871
AC:
13320
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.973
AC:
3377
AN:
3472
East Asian (EAS)
AF:
0.855
AC:
4387
AN:
5128
South Asian (SAS)
AF:
0.919
AC:
4442
AN:
4832
European-Finnish (FIN)
AF:
0.978
AC:
10393
AN:
10624
Middle Eastern (MID)
AF:
0.932
AC:
274
AN:
294
European-Non Finnish (NFE)
AF:
0.963
AC:
65463
AN:
67998
Other (OTH)
AF:
0.878
AC:
1853
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
786
1572
2358
3144
3930
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
880
1760
2640
3520
4400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.916
Hom.:
11938
Bravo
AF:
0.832
Asia WGS
AF:
0.859
AC:
2988
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Feb 08, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 21, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency Benign:1
-
Pecori Giraldi Lab, University of Milan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:case-control

This variant is intronic -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.22
DANN
Benign
0.38
PhyloP100
-2.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4732516; hg19: chr7-75614082; API